Holen Sie sich die Stockscreener-App
63.02
0.40%
0.25
Handel nachbörslich:
64.19
1.17
+1.86%
Schlusskurs vom Vortag:
$62.77
Offen:
$62.8
24-Stunden-Volumen:
3.22M
Relative Volume:
0.86
Marktkapitalisierung:
$12.37B
Einnahmen:
$13.65B
Nettoeinkommen (Verlust:
$169.86M
KGV:
58.58
EPS:
1.0758
Netto-Cashflow:
$412.12M
1W Leistung:
-9.15%
1M Leistung:
-8.71%
6M Leistung:
+64.29%
1J Leistung:
+217.48%
1-Tages-Spanne:
$61.58
$64.25
1-Wochen-Bereich:
$57.95
$73.29
52-Wochen-Spanne:
$19.51
$73.75
Brightspring Health Services Inc Stock (BTSG) Company Profile
Firmenname
Brightspring Health Services Inc
Sektor
Branche
Telefon
502-394-2100
Adresse
805 N. WHITTINGTON PARKWAY, LOUISVILLE
Compare BTSG vs VEEV, HQY, TEM, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BTSG
Brightspring Health Services Inc
|
63.02 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
VEEV
Veeva Systems Inc
|
213.51 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
HQY
Healthequity Inc
|
104.41 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
46.70 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
HNGE
Hinge Health Inc
|
80.79 | 5.81B | 646.34M | -512.40M | 202.76M | -6.6871 |
Brightspring Health Services Inc Stock (BTSG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-12 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-11 | Eingeleitet | Stephens | Overweight |
| 2025-12-08 | Eingeleitet | William Blair | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-06-23 | Eingeleitet | TD Cowen | Buy |
| 2024-12-12 | Eingeleitet | CJS Securities | Market Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-21 | Eingeleitet | BTIG Research | Buy |
| 2024-03-06 | Eingeleitet | HSBC Securities | Buy |
| 2024-02-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-02-20 | Eingeleitet | BofA Securities | Buy |
| 2024-02-20 | Eingeleitet | Deutsche Bank | Hold |
| 2024-02-20 | Eingeleitet | Goldman | Buy |
| 2024-02-20 | Eingeleitet | Guggenheim | Buy |
| 2024-02-20 | Eingeleitet | Jefferies | Buy |
| 2024-02-20 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-20 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-02-20 | Eingeleitet | UBS | Buy |
| 2024-02-20 | Eingeleitet | Wells Fargo | Overweight |
Alle ansehen
Brightspring Health Services Inc Aktie (BTSG) Neueste Nachrichten
Brightspring Health Services Inc - TradingKey
BlackRock (BTSG holder) discloses 12% BrightSpring Health Services ownership in 13G/A - Stock Titan
Brightspring Health Services Inc (BTSG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BrightSpring Health Services, Inc. (BTSG) Stock Analysis: A Healthcare Giant with 25.6% Revenue Growth and Strong Buy Ratings - DirectorsTalk Interviews
Brightspring Health Services Inc (BTSG) Cash Flow - TradingKey
BTSG|Brightspring Health Services Inc|Price:72.910|Chg%:+3.070 - TradingKey
2 Reasons to Like BTSG (and 1 Not So Much) - Yahoo Finance
BrightSpring Health Services, Inc. (BTSG) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
BTSG Q2'26 Earnings: revenue estimate is 3.66B USD - TradingView
Brightspring Health Services Inc (BTSG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Responsive Playbooks and the BTSGU Inflection - Stock Traders Daily
Behavioral Patterns of BTSG and Institutional Flows - Stock Traders Daily
BrightSpring Health Services, Inc. Stock 12‑Month Price Target Raised to $78, Implies 12% Upside - TradingView
BrightSpring Health Services (NASDAQ:BTSG): High Growth Momentum Stock Flashing a Breakout Setup - ChartMill
ETFs Investing in BrightSpring Health Services, Inc. Units Stocks - TradingView
Top Definium Therapeutics (DFTX) Competitors 2026 - MarketBeat
BrightSpring Health Services (BTSG): Growth Potential In Healthcare With A 7.51% Upside - DirectorsTalk Interviews
BrightSpring Health Services (BTSG) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
ETFs Investing in BrightSpring Health Services, Inc. Stocks - TradingView
Does BrightSpring’s S&P 400 Reclassification Alter the Bull Case for BrightSpring Health Services (BTSG)? - simplywall.st
Are medical stocks lagging BrightSpring Health Services, Inc. (BTSG) this year? - MSN
BrightSpring Health Services, Inc.(NasdaqGS: BTSG) added to S&P 400 - marketscreener.com
BrightSpring Health Services, Inc.(NasdaqGS:BTSG) dropped from S&P 600 Health Care Services (Sub Ind) - marketscreener.com
BrightSpring Health Services, Inc.(NasdaqGS: BTSG) dropped from S&P 600 Health Care - marketscreener.com
BrightSpring Health Services, Inc.(NasdaqGS: BTSG) dropped from S&P 600 - marketscreener.com
Goldman Sachs Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $80 - Moomoo
Why Is BrightSpring Health Services (NASDAQ:BTSG) Featured Among Midcap Stocks? - Kalkine Media
BrightSpring enters S&P MidCap 400 as Karman joins SmallCap 600 - Stock Titan
Analysts Conflicted on These Healthcare Names: BrightSpring Health Services, Inc. (BTSG) and Incyte (INCY) - The Globe and Mail
BrightSpring Health Services, Inc. Stock 12‑Month Price Target Raised to $76.76, Implies 10% Upside - TradingView
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $80 - Moomoo
A Quick Look at Today's Ratings for BrightSpring Health Services(BTSG.US), With a Forecast Between $78 to $86 - Moomoo
Morgan Stanley Raises Price Target on BrightSpring Health Services to $80 From $71, Keeps Overweight Rating - Moomoo
BrightSpring Health Services, Inc. Stock 12‑Month Price Target Raised to $76.24, Implies 9% Upside - TradingView
Here's why you should add BrightSpring stock to your portfolio now - MSN
Guggenheim Initiates Coverage on BrightSpring Health Services With Buy Rating, $81 Price Target - marketscreener.com
Guggenheim Initiates BrightSpring Health Services(BTSG.US) With Buy Rating, Announces Target Price $81 - Moomoo
BrightSpring Health Services, I (BTSG): Investor Outlook Amid Strong Revenue Growth and Robust Analyst Ratings - DirectorsTalk Interviews
BrightSpring Health Services, Inc. (BTSG) is a great momentum stock: Should you buy? - MSN
Teladoc Health broadens virtual care reach through Walmart platform - MSN
Raymond James Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $80 - Moomoo
Jon Rousseau: Princeton Scholar, Healthcare Operator, and Chairman, President and Chief Executive Officer of BrightSpring Health Services - BBN Times
BrightSpring Health Services (BTSG) Q1 2026 Earnings Call Transcript - Fortune
This Travelers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
BTSG Initiated Coverage by Raymond James -- Rating Set to Outper - GuruFocus
Raymond James initiates BrightSpring Health stock with outperform rating - Investing.com
BrightSpring Health Services: Future Expectations May Be Fully Priced In - Seeking Alpha
BrightSpring Health Services to announce Q2 2026 results on July 31 - scanx.trade
BTSG Maintained by UBS -- Price Target Raised to $85.00 - GuruFocus
BrightSpring schedules Q2 results and 8:30 a.m. call for July 31 - Stock Titan
BrightSpring Health Services, Inc. to Announce Second Quarter 2026 Financial Results on July 31, 2026 - The Manila Times
Finanzdaten der Brightspring Health Services Inc-Aktie (BTSG)
Umsatz
Nettogewinn
Free Cashflow
ENV
Brightspring Health Services Inc-Aktie (BTSG) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| KKR Phoenix Aggregator L.P. | 10% Owner |
Jun 05 '26 |
Sale |
58.45 |
14,669,771 |
857,492,124 |
27,154,488 |
| ROUSSEAU JON B | See Remarks |
Jun 05 '26 |
Option Exercise |
6.37 |
130,000 |
828,100 |
130,000 |
| ROUSSEAU JON B | See Remarks |
Jun 05 '26 |
Option Exercise |
6.37 |
130,000 |
828,100 |
1,324,503 |
| ROUSSEAU JON B | See Remarks |
Jun 05 '26 |
Sale |
58.75 |
130,000 |
7,637,500 |
0 |
| ROUSSEAU JON B | See Remarks |
Jun 05 '26 |
Sale |
58.75 |
130,000 |
7,637,500 |
1,194,503 |
| Nalley Lisa A | See Remarks |
Jun 05 '26 |
Option Exercise |
6.37 |
35,000 |
222,950 |
166,948 |
| Nalley Lisa A | See Remarks |
Jun 05 '26 |
Sale |
58.75 |
35,000 |
2,056,250 |
131,948 |
| Phipps Jennifer A | Chief Financial Officer |
Jun 05 '26 |
Option Exercise |
6.37 |
35,000 |
222,950 |
285,224 |
| Phipps Jennifer A | Chief Financial Officer |
Jun 05 '26 |
Sale |
58.75 |
35,000 |
2,056,250 |
250,224 |
0.53%
1.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):